Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$601M |
| 2 |
Moderna
MRNA
|
+$557M |
| 3 |
Analog Devices
ADI
|
+$448M |
| 4 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$445M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$406M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$652M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$512M |
| 3 |
TSMC
TSM
|
+$378M |
| 4 |
JPMorgan Chase
JPM
|
+$318M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
+$305M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.12% |
| 2 | Financials | 12.68% |
| 3 | Healthcare | 12.53% |
| 4 | Consumer Discretionary | 11.26% |
| 5 | Communication Services | 9.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
Park-Ohio Holdings
PKOH
$575M
| $1.97M | ﹤0.01% |
77,210
-6,322
| -8% | -$172K |
|
|
MIC
3302
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $1.97M | ﹤0.01% |
48,564
-744,874
| -94% | -$29.4M |
|
3303
Tonix Pharmaceuticals
TNXP
$160M
| $1.96M | ﹤0.01% |
5
| – | – |
|
|
VINC
3304
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $1.95M | ﹤0.01% |
6,018
+2,811
| +88% | +$820K |
|
3305
Bioventus
BVS
$892M
| $1.94M | ﹤0.01% |
137,012
+42,987
| +46% | +$661K |
|
|
SQSP
3306
DELISTED
Squarespace, Inc.
SQSP
| $1.94M | ﹤0.01% |
+50,204
| New | +$2.43M |
|
3307
Escalade
ESCA
$273M
| $1.94M | ﹤0.01% |
102,492
-4,568
| -4% | -$101K |
|
|
GBL
3308
DELISTED
GAMCO Investors, Inc.
GBL
| $1.93M | ﹤0.01% |
73,160
-6,690
| -8% | -$179K |
|
3309
Immuneering
IMRX
$267M
| $1.93M | ﹤0.01% |
+72,612
| New | +$1.95M |
|
3310
HF Foods Group
HFFG
$80.2M
| $1.93M | ﹤0.01% |
318,542
-25,535
| -7% | -$142K |
|
3311
Nathan's Famous
NATH
$402M
| $1.93M | ﹤0.01% |
31,490
-309
| -1% | -$20.4K |
|
|
ASTR
3312
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
| $1.92M | ﹤0.01% |
+14,732
| New | +$2.25M |
|
|
TRVN
3313
DELISTED
Trevena, Inc.
TRVN
| $1.92M | ﹤0.01% |
2,497
+1,564
| +168% | +$1.33M |
|
3314
Edgewise Therapeutics
EWTX
$4.13B
| $1.92M | ﹤0.01% |
115,573
-11,156
| -9% | -$202K |
|
3315
Teekay
TK
$1.01B
| $1.92M | ﹤0.01% |
523,044
-24,822
| -5% | -$78.1K |
|
3316
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$6B
| $1.91M | ﹤0.01% |
55,898
+23,208
| +71% | +$823K |
|
|
ADVM
3317
DELISTED
Adverum Biotechnologies
ADVM
| $1.9M | ﹤0.01% |
87,714
-4,476
| -5% | -$114K |
|
3318
Concrete Pumping Holdings
BBCP
$490M
| $1.89M | ﹤0.01% |
221,594
-6,639
| -3% | -$55.8K |
|
3319
Hims & Hers Health
HIMS
$6.43B
| $1.89M | ﹤0.01% |
250,043
+95,363
| +62% | +$808K |
|
|
PZN
3320
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $1.89M | ﹤0.01% |
191,595
-8,500
| -4% | -$91K |
|
|
PAMT
3321
PAMT Corp
PAMT
$337M
| $1.89M | ﹤0.01% |
83,850
-6,910
| -8% | -$119K |
|
3322
FlexShares Ultra-Short Income Fund
RAVI
$1.48B
| $1.88M | ﹤0.01% |
2,322,354
-51,594
| -2% | -$3.93M |
|
|
PSTX
3323
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $1.87M | ﹤0.01% |
257,061
+11,992
| +5% | +$103K |
|
|
DZSI
3324
DELISTED
DZS Inc. Common Stock
DZSI
| $1.87M | ﹤0.01% |
152,738
-5,369
| -3% | -$84.5K |
|
3325
Vanguard Consumer Discretionary ETF
VCR
$6.15B
| $1.86M | ﹤0.01% |
6,013
+39
| +0.7% | +$12.4K |
|
Similar funds
Northern Trust's Q3 2021 Portfolio in Review
As of Q3 2021, Northern Trust held 4,828 positions worth $565B, down 0.48% from $568B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Northern Trust's Q3 2021 filing shows 242 new, 1,428 increased, 2,705 reduced and 176 closed positions. Its largest new stake was Dimensional International Value ETF: 4,656,805 shares worth $152M. The largest sale was Alphabet (Google) Class C, an estimated $652M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Northern Trust's largest Q3 2021 buy was Dimensional International Value ETF: 4,656,805 shares worth $152M.
- Northern Trust added most to Johnson & Johnson in Q3 2021, an estimated $601M increase.
- Northern Trust's biggest Q3 2021 reduction was Alphabet (Google) Class C, cutting an estimated $652M.
- Northern Trust fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $512M.
- Northern Trust's ten largest holdings make up 22% of its $565B portfolio in Q3 2021.
- Northern Trust opened 242 new positions and closed 176 in Q3 2021.
- Northern Trust's portfolio value fell 0.48% quarter-over-quarter to $565B.
Based on Northern Trust's 13F filing for Q3 2021, filed 15 Nov 2021.